This business develops and markets unique nutritional and blended OTC products utilizing a patented Nanofluidization process to develop new products within the pharmaceutical market and nutritional markets. The company is committed to pioneering new low dosage products that eliminate many of the negative effects (CONTRA INDICATORS) associated with OTC drugs. Growth perspectives are immense. Two products are in place. Products are administered via sub lingual spray.
$15,000,000
Undisclosed
(last 12 months)Undisclosed
(last 12 months)Undisclosed
If you are interested in finding out more information, please contact the seller.
Bizilla Reference # 17483 : Report this listing